Meta-analysis of complications in aortic valve replacement: Comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 1, 2012, Pages 128-138

  Jilaihawi, Hasan ^a   Chakravarty, Tarun ^a   Weiss, Robert E ^b   Fontana, Gregory P ^c   Forrester, James ^a   Makkar, Raj R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LENOX HILL HOSPITAL   (United States)

Author keywords

aortic valve replacement; AVR; complications; random effects meta analysis; SAVR; TAVR; transcatheter aortic valve implantation

Indexed keywords

AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CEREBROVASCULAR ACCIDENT; COMPARATIVE EFFECTIVENESS; CORONARY ARTERY BYPASS GRAFT; ELDERLY CARE; FUNCTIONAL STATUS; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; LUNG DISEASE; META ANALYSIS; PACEMAKER; POSTOPERATIVE COMPLICATION; RENAL REPLACEMENT THERAPY; SCORING SYSTEM; SURGICAL AORTIC VALVE REPLACEMENT; SURGICAL MORTALITY; SYSTEMATIC REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BAYES THEOREM; CARDIAC CATHETERIZATION; COMORBIDITY; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; LOGISTIC MODELS; MALE; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84862887730     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23368     Document Type: Article

References (53)

1. Otto CM,. Calcific aortic stenosis-Time to look more closely at the valve. N Engl J Med 2008; 359: 1395-1398.
2. Carabello BA, Paulus WJ,. Aortic stenosis. Lancet 2009; 373: 956-966.
3. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106: 3006-3008. (Pubitemid 35440280)
4. Webb JG,. Percutaneous aortic valve replacement will become a common treatment for aortic valve disease. JACC Cardiovasc Interv 2008; 1: 122-126. (Pubitemid 351509301)
5. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2011; 363: 1597-1607.
6. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364: 2187-2198.
7. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010; 122: 62-69.
8. Gotzmann M, Hehen T, Germing A, et al. Short-term effects of transcatheter aortic valve implantation on neurohormonal activation, quality of life and 6-minute walk test in severe and symptomatic aortic stenosis. Heart 2010; 96: 1102-1106.
9. Baan J, Jr., Yong ZY, Koch KT, et al. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the corevalve prosthesis. Am Heart J 2010; 159: 497-503.
10. Petronio AS, De Carlo M, Bedogni F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv 2010; 3: 359-366.
11. Koos R, Mahnken AH, Dohmen G, et al. Association of aortic valve calcification severity with the degree of aortic regurgitation after transcatheter aortic valve implantation. Int J Cardiol 2010; 150: 142-145.
12. John D, Buellesfeld L, Yuecel S, et al. Correlation of device landing zone calcification and acute procedural success in patients undergoing transcatheter aortic valve implantations with the self-expanding corevalve prosthesis. JACC Cardiovasc Interv 2010; 3: 233-243.
13. Piazza N, Wenaweser P, van Gameren M, et al. Relationship between the logistic EuroSCORE and the society of thoracic surgeons predicted risk of mortality score in patients implanted with the corevalve revalving system-A Bern-Rotterdam study. Am Heart J 2010; 159: 323-329.
14. Rodes-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010; 55: 1080-1090.
15. Pasic M, Unbehaun A, Dreysse S, et al. Transapical aortic valve implantation in 175 consecutive patients: excellent outcome in very high-risk patients. J Am Coll Cardiol 2010; 56: 813-820.
16. Bosmans J., The Belgian TAVI Registry. EuroPCR Meeting 2010. Paris, France; 2010.
17. Eltchaninoff H., France Registry. EuroPCR Meeting 2010. Paris, France; 2010.
18. Ludman P., UK TAVI Registry. EuroPCR Meeting 2010. Paris, France; 2010.
19. Thomas M., The Expanded (including cohort 2) SOURCE Registry: 30-day Outcomes from 2,300 Edwards TAVI Patients and Predictors of Mortality. Transcatheter Cardiovascular Therapeutics. Washington, DC, 2010.
20. Avanzas P, Munoz-Garcia AJ, Segura J, et al. Percutaneous implantation of the CoreValve self-expanding aortic valve prosthesis in patients with severe aortic stenosis: early experience in Spain. Rev Esp Cardiol 2010; 63: 141-148.
21. Meredith I., The Australia-New Zealand medtronic corevalve registry: VARC-adjudicated outcomes in inoperable and high risk AS patients. Transcatheter Cardiovascular Therapeutics. Washington, DC, 2010.
22. Leon M., PARTNER: A prospective randomized trial of transcatheter aortic valve implantation compared to standard therapy in patients with inoperable aortic stenosis. Transcatheter Cardiovascular Therapies Meeting. Washington, D.C., 2010.
23. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New Engl J Med 2010; 363: 1597-1607.
24. Kolh P, Kerzmann A, Lahaye L, Gerard P, Limet R,. Cardiac surgery in octogenarians; peri-operative outcome and long-term results. Eur Heart J 2001; 22: 1235-1243. (Pubitemid 32702960)
25. Brunvand H, Offstad J, Nitter-Hauge S, Svennevig JL,. Coronary artery bypass grafting combined with aortic valve replacement in healthy octogenarians does not increase postoperative risk. Scand Cardiovasc J 2002; 36: 297-301. (Pubitemid 35363863)
26. Chiappini B, Camurri N, Loforte A, Di Marco L, Di Bartolomeo R, Marinelli G,. Outcome after aortic valve replacement in octogenarians. Ann Thorac Surg 2004; 78: 85-89. (Pubitemid 38833905)
27. Vaquette B, Corbineau H, Laurent M, et al. Valve replacement in patients with critical aortic stenosis and depressed left ventricular function: predictors of operative risk, left ventricular function recovery, and long term outcome. Heart 2005; 91: 1324-1329. (Pubitemid 41360953)
28. Langanay T, Verhoye JP, Ocampo G, et al. Current hospital mortality of aortic valve replacement in octogenarians. J Heart Valve Dis 2006; 15: 630-637; discussion 637.
29. Melby SJ, Zierer A, Kaiser SP, et al. Aortic valve replacement in octogenarians: risk factors for early and late mortality. Ann Thorac Surg 2007; 83: 1651-1656; discussion 1656-1657.
30. Filsoufi F, Rahmanian PB, Castillo JG, Chikwe J, Silvay G, Adams DH,. Results and predictors of early and late outcomes of coronary artery bypass graft surgery in octogenarians. J Cardiothorac Vasc Anesth 2007; 21: 784-792. (Pubitemid 350192293)
31. Bose AK, Aitchison JD, Dark JH,. Aortic valve replacement in octogenarians. J Cardiothorac Surg 2007; 2: 33.
32. Roberts WC, Ko JM, Garner WL, et al. Valve structure and survival in octogenarians having aortic valve replacement for aortic stenosis (+/- aortic regurgitation) with versus without coronary artery bypass grafting at a single US medical center (1993 to 2005). Am J Cardiol 2007; 100: 489-495. (Pubitemid 47096822)
33. de Vincentiis C, Kunkl AB, Trimarchi S, et al. Aortic valve replacement in octogenarians: is biologic valve the unique solution? Ann Thorac Surg 2008; 85: 1296-1301. (Pubitemid 351384796)
34. Pai RG, Varadarajan P, Razzouk A,. Survival benefit of aortic valve replacement in patients with severe aortic stenosis with low ejection fraction and low gradient with normal ejection fraction. Ann Thorac Surg 2008; 86: 1781-1789.
35. Maillet JM, Somme D, Hennel E, Lessana A, Saint-Jean O, Brodaty D,. Frailty after aortic valve replacement (AVR) in octogenarians. Arch Gerontol Geriatr 2009; 48: 391-396.
36. Leontyev S, Walther T, Borger MA, et al. Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE. Ann Thorac Surg 2009; 87: 1440-1445.
37. Florath I, Albert A, Boening A, Ennker IC, Ennker J,. Aortic valve replacement in octogenarians: Identification of high-risk patients. Eur J Cardiothorac Surg 2010; 37: 1304-1310.
38. Maslow A, Casey P, Poppas A, Schwartz C, Singh A,. Aortic valve replacement with or without coronary artery bypass graft surgery: The risk of surgery in patients > or =80 years old. J Cardiothorac Vasc Anesth 2010; 24: 18-24.
39. Carnero-Alcazar M, Reguillo-Lacruz F, Alswies A, Villagran-Medinilla E, Maroto-Castellanos LC, Rodriguez-Hernandez J,. Short- and mid-term results for aortic valve replacement in octogenarians. Interact Cardiovasc Thorac Surg 2010; 10: 549-554.
40. Boning A, Lutter G, Mrowczynski W, et al. Octogenarians undergoing combined aortic valve replacement and myocardial revascularization: perioperative mortality and medium-term survival. Thorac Cardiovasc Surg 2010; 58: 159-163.
41. Ding WH, Lam YY, Pepper JR, et al. Early and long-term survival after aortic valve replacement in septuagenarians and octogenarians with severe aortic stenosis. Int J Cardiol 2010; 141: 24-31.
42. Walther T, Schuler G, Borger MA, et al. Transapical aortic valve implantation in 100 consecutive patients: comparison to propensity-matched conventional aortic valve replacement. Eur Heart J 2010; 31: 1398-1403.
43. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the corevalve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006; 114: 1616-1624. (Pubitemid 44547432)
44. Dumesnil JG, Pibarot P, Carabello B,. Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment. Eur Heart J 2010; 31: 281-289.
45. Lunn DJ TA, Best N, Spiegelhalter D,. WinBUGS-A Bayesian modelling framework: Concepts, structure, and extensibility. Stat Comput 2000; 10: 325-337.
46. Lin Y, Lipsitz S, Sinha D, Gawande AA, Regenbogen SE, Greenberg CC,. Using Bayesian p-values in a 2 × 2 table of matched pairs with incompletely classified data. J R Stat Soc Ser C Appl Stat 2009; 58: 237-246.
47. Piazza N, van Gameren M, Juni P, et al. A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: A two-centre study. EuroIntervention 2009; 5: 580-588.
48. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding corevalve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007; 50: 69-76. (Pubitemid 46970878)
49. Surgeons TSoT. Online STS Risk Calculator.
50. Kobayashi KJ, Williams JA, Nwakanma L, Gott VL, Baumgartner WA, Conte JV,. Aortic valve replacement and concomitant coronary artery bypass: assessing the impact of multiple grafts. Ann Thorac Surg 2007; 83: 969-978. (Pubitemid 46328822)
51. Jones M, Schofield PM, Brooks NH, et al. Aortic valve replacement with combined myocardial revascularisation. Br Heart J 1989; 62: 9-15. (Pubitemid 19171229)
52. Dunson DB,. Commentary: practical advantages of Bayesian analysis of epidemiologic data. Am J Epidemiol 2001; 153: 1222-1226. (Pubitemid 32552281)
53. Weiss RE,. Bayesian methods for data analysis. Am J Ophthalmol 2010; 149: 187-188e1.